Modafinil (Provigil) Global Regulatory Status
A detailed review of modafinil's FDA approval history, international scheduling, labeled indications, and post-market safety actions across the US, EU, UK, Australia, and other major markets.
Modafinil: Regulatory History
8 source-based articles maintained by the HealthRX.com Editorial Team.
8articles
4topic areas covered
May 26, 2026latest review
Modafinil: Regulatory History library
Showing 8 of 8 clinical reviews.
Provigil (Modafinil) FAERS Safety Signals: Post-Market Surveillance Data Reviewed
A analysis of FDA Adverse Event Reporting System (FAERS) safety signals for Provigil (modafinil), including serious skin reactions, psychiatric events, and cardiovascular reports.
Provigil (Modafinil) FDA Approval History: Timeline, Label Changes, and Safety Updates
A complete timeline of Provigil (modafinil) FDA approval, label revisions, post-market safety actions, and current regulatory status for narcolepsy, OSA, and shift-work disorder.
Provigil Compounding Legal Status: What Patients and Prescribers Need to Know About Modafinil
A clinical guide to the FDA regulatory status of modafinil (Provigil), its compounding eligibility under federal law, and what prescribers should understand about 503A and 503B pathways.
Provigil EMA vs FDA Approach: How Two Regulators Diverged on Modafinil
A clinical comparison of how the FDA and EMA approved, labeled, and monitored modafinil (Provigil), including approved indications, label differences, post-market surveillance, and what each agency's decisions mean for prescribers today.
Provigil Label Updates 2020 to 2026: What Changed and Why It Matters
The FDA modafinil label warns of serious rash (SJS, TEN, DRESS), psychiatric events like mania and suicidal ideation, and cardiac caution in heart disease.
Provigil Legal & Patent Challenges: FDA Approval, Label, and Safety Record
A complete guide to Provigil (modafinil) regulatory history, patent litigation, FDA labeling requirements, and post-market safety findings, with citations to primary sources.
Provigil Pipeline and Next-Gen Wakefulness Agents: What Comes After Modafinil?
A clinical review of the modafinil regulatory timeline, current generic market, and next-generation wakefulness-promoting agents in development or recently approved.